Novacyt Full Year 2014 Results

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its audited financial statement for the year ending 31st December, 2014,  approved by the Board of Directors on the 28th April 2015. Download press release

Visit Page

Novacyt raises €2.2M to accelerate NOVAPREP launch in China and announces strong first quarter sales growth

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces a private equity placement financing of €2.2m. This new financing will be used to accelerate the launch of NOVAprep® into China with its distribution partner Leica Biosystems, now scheduled for Q2 2015. This follows the successful financing of €3.1m in December

Visit Page

Novacyt appoints new Group Commercial Director

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has appointed Manuela Gazzard as Commercial Director. Download press release

Visit Page